Menu
AfPA’s Hepatitis Therapy Access Working Group is a network of policy-minded health care providers who advocate for patient-centered care.
By participating in advocacy initiatives and the development of educational resources, working group members ensure that the clinician’s perspective informs policy discussions that impact health care for people living with hepatitis.
To learn more, or to join AfPA’s Hepatitis Therapy Access Working Group, please email [email protected]. Frederick L. Altice, MD, serves as chairman of AfPA’s Hepatitis Therapy Access Working Group. A passionate clinician, researcher and advocate for informed public policies that support optimal treatments for patients living with HCV to reduce health disparities, Dr. Altice is a Professor of Medicine and Public Health at Yale University, where he is the Director of Clinical and Community Research. Dr. Altice is board certified in internal medicine, infectious diseases and addiction medicine.
